Literature DB >> 19170744

Age of puberty and the risk of multiple sclerosis: a population based study.

S V Ramagopalan1, W Valdar, M Criscuoli, G C DeLuca, D A Dyment, S-M Orton, I M Yee, G C Ebers, A D Sadovnick.   

Abstract

BACKGROUND AND
PURPOSE: Genetic and environmental factors have important roles in multiple sclerosis (MS) susceptibility. Given a potential role for sex hormones in MS, we have investigated whether or not the age of puberty influences the risk of developing MS in a population-based cohort.
METHODS: We identified 5493 MS index cases and 1759 spousal controls with age of puberty information from the Canadian Collaborative Project on Genetic Susceptibility to MS. Age of puberty was compared between index cases and controls, and any effect of age of puberty on the age of onset of MS was also investigated.
RESULTS: There were no significant differences between male index cases and controls with respect to age of puberty, P = 0.70. However, a significant difference was observed between female index cases and female controls, with average age of puberty being 12.4 and 12.6 years respectively, P = 0.00017, providing a relative risk decrease of 0.9 per year increase of age of puberty. There was no effect of the age of puberty on the age of MS onset in either sex.
CONCLUSIONS: Earlier age at menarche increases the risk of MS in women. Whether this association is a surrogate for a disease causative factor or directly involved in MS disease aetiology needs to be uncovered.

Entities:  

Mesh:

Year:  2009        PMID: 19170744     DOI: 10.1111/j.1468-1331.2008.02431.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  24 in total

1.  A longitudinal assessment of early pubertal timing as a predictor of psychosocial changes in adolescent girls with and without spina bifida.

Authors:  Rachel M Wasserman; Grayson N Holmbeck; Jaclyn M Lennon; Christina M Amaro
Journal:  J Pediatr Psychol       Date:  2012-01-23

Review 2.  Menopause in multiple sclerosis: therapeutic considerations.

Authors:  Riley Bove; Tanuja Chitnis; Maria Houtchens
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

3.  Breastfeeding, ovulatory years, and risk of multiple sclerosis.

Authors:  Annette Langer-Gould; Jessica B Smith; Kerstin Hellwig; Edlin Gonzales; Samantha Haraszti; Corinna Koebnick; Anny Xiang
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

Review 4.  The importance of studying sex differences in disease: The example of multiple sclerosis.

Authors:  Lisa C Golden; Rhonda Voskuhl
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  Menarche increases relapse risk in pediatric multiple sclerosis.

Authors:  Sabeen Lulu; Jennifer Graves; Emmanuelle Waubant
Journal:  Mult Scler       Date:  2015-05-06       Impact factor: 6.312

Review 6.  Caring for Women with Multiple Sclerosis Across the Lifespan.

Authors:  Kelsey Rankin; Riley Bove
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

Review 7.  Environmental factors and their timing in adult-onset multiple sclerosis.

Authors:  Adam E Handel; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

8.  Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis.

Authors:  M B D'hooghe; P Haentjens; G Nagels; T D'Hooghe; J De Keyser
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

Review 9.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

Review 10.  Sex differences in autoimmune disorders of the central nervous system.

Authors:  Stefan M Gold; Anne Willing; Frank Leypoldt; Friedemann Paul; Manuel A Friese
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.